Navigation Links
Arena Pharmaceuticals Announces First Quarter 2009 Financial Results
Date:5/11/2009

lopment expenses, which totaled $42.6 million in the first quarter of 2009, declined from $47.4 million in the first quarter of 2008. This decrease in research and development expenses is primarily attributable to decreased clinical trial costs due to the completion of clinical and preclinical studies as Arena prioritized its spending towards the completion of trials for lorcaserin. Research and development expenses are expected to continue to significantly decline throughout the year as the lorcaserin pivotal Phase 3 studies complete. Research and development expenses included $0.9 million in non-cash, share-based compensation expense in the quarter ended March 31, 2009, compared to $1.0 million in the quarter ended March 31, 2008. General and administrative expenses totaled $7.6 million in the first quarter of 2009, compared to $8.9 million in the first quarter of 2008. This decrease in general and administrative expenses is primarily attributable to decreased patent costs. General and administrative expenses in the first quarter of 2009 included $1.1 million in non-cash, share-based compensation expense, compared to $1.4 million in the first quarter of 2008.

At March 31, 2009, cash, cash equivalents and short-term investments totaled $70.3 million and approximately 74.3 million shares of common stock were outstanding.

In April 2009, Arena received aggregate net proceeds of $14.6 million from the sale of approximately 5.7 million shares under a $50.0 million equity financing commitment entered into in March 2009 with Azimuth Opportunity Ltd., or Azimuth.

Arena's First Quarter and Recent Developments

  • Abstract accepted for presentation of data from BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), the first of two pivotal trials evaluating the safety and efficacy of lorcaserin for weight management, at the 69th Scientific Sessions of t
    '/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
2. Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
3. Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
4. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
5. Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008
6. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
7. Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
10. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
11. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 01, 2014 Chantel Lee ’15 and Eli ... 10 40-hour weeks with Dr. Juan Rodriguez, Professor of Physics, ... a common diabetic eye disease caused by changes in the ... and Eli accomplished is quite remarkable,” said Rodriguez. “They took ... when they started, and together carried it to near completion ...
(Date:8/1/2014)... Dallas, Texas (PRWEB) August 01, 2014 ... current state of the Ammonium Bicarbonate industry in Global ... the industry, including definitions, applications and industry chain structure. ... provided with a focus on history, developments, trends and ... international and Chinese situation is also offered. , The ...
(Date:8/1/2014)... 01, 2014 RURO, Inc., Laboratory ... today officially announces the opening of its first ... Park, Baoshan District in Shanghai, PRC, RURO Shanghai’s ... the management of Mr. Shen Gang, the former ... past three years, RURO’s has installed FreezerPro-based solutions ...
(Date:8/1/2014)... 1, 2014 AACC, a global scientific and ... medicine, unveiled an updated brand identity today that reflects ... the changing healthcare environment and continue to do what ... patients get the care they need. ... play an essential role in saving lives and making ...
Breaking Biology Technology:Two Centenary College Students Tackle Diabetic Retinopathy Research 2Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 2Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 3RURO Opens Office in Shanghai, China 2AACC Debuts Refreshed Brand Identity 2
... Scientists at the University of Toronto have developed a new ... tissue to identify women at risk of breast cancer much ... hormone estrogen and its metabolites the products of metabolized ... increased in breast cancer patients compared to healthy women, and ...
... A team of Spanish scientists from a variety of ... the peridunal lagoons in the Doana National Park. Results ... regressing, largely due to the extraction of underground water ... effects of the ecosystem itself are further aggravating the ...
... , Third Quarter 2009 Financial Results , VANCOUVER, Oct. 9 ... host a conference call discussing its financial results for the ... 2009 at 11:00 AM ET (8:00 AM Pacific). , , ... November 9, 2009 is as, follows:, ...
Cached Biology Technology:New lab-on-a-chip technique developed at U of T 2Huelva is swallowing up coastal lagoons in Doñana 2
(Date:8/1/2014)... in the fossil record about 200,000 years ago, but ... art and advanced tools became widespread. , A ... Current Anthropology finds that human skulls changed in ... around the same time that culture was blossoming. , ... and rapid cultural exchange probably came at the same ...
(Date:8/1/2014)... Advances in stem cell research will provide enormous ... Basically, stem cells could replicate any other cells ... Alzheimer,s disease, repairing damaged spinal cords, treating kidney, ... whole. The potential for profit is staggering. Prof. ... that this field of research still faces myriad ...
(Date:8/1/2014)... patients may soon have a more effective way to ... by researchers from the National University of Singapore (NUS). ... from the Department of Pharmacology at the NUS Yong ... Ho Wanxing, a recent PhD graduate from the Saw ... that artesunate, a common herbal-based anti-malarial drug, can be ...
Breaking Biology News(10 mins):Society bloomed with gentler personalities and more feminine faces 2NUS study shows effectiveness of common anti-malarial drug in controlling asthma 2
... ARBORDarwin referred to the origin of species as "that mystery ... evolutionary biologists cannot fully explain how new animals and plants ... has been based on the assumption that the main cause ... is the formation of barriers to reproduction between populations. ...
... -- A collaborative project involving a Kansas State University ... helped forest systems recover from decades of sulfur pollution ... included Jesse Nippert, associate professor of biology -- spent ... Juniperus virginiana , in the Central Appalachian Mountains ...
... males increased by an unprecedented 11cm between the mid-nineteenth ... online today in the journal Oxford Economic Papers ... average height actually accelerated in the period spanning the ... J. Hatton, Professor of Economics at the University of ...
Cached Biology News:Long-held assumption about emergence of new species questioned 2Long-held assumption about emergence of new species questioned 3Red cedar tree study shows that Clean Air Act is reducing pollution, improving forests 2Red cedar tree study shows that Clean Air Act is reducing pollution, improving forests 3New data reveals that the average height of European males has grown by 11cm in just over a century 2
Recombinant Rhesus Macaque IFN-alpha...
chk 1 kinase...
...
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
Biology Products: